Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAF(V600E) metastatic colorectal cancer
恩科拉非尼、西妥昔单抗和纳武利尤单抗治疗微卫星稳定型BRAF(V600E)转移性结直肠癌的I/II期临床试验
期刊:Cancer Cell
影响因子:44.5
doi:10.1016/j.ccell.2025.08.002
Morris, Van K; Parseghian, Christine M; Bahrambeigi, Vahid; Abdelfattah, Nourhan; Xiao, Lianchun; Agrawal, Anjali; Lin, Kangyu; Raghav, Kanwal P S; Wolff, Robert A; Dasari, Arvind; Huey, Ryan W; Kee, Bryan K; Overman, Michael J; Willis, Jason A; Le, Phat H; Escano, Michelle; Baig, Yunyu C; Pan, Kelsey; Menter, David; Tam, Alda L; Foo, Wai C; Shen, Li; Lee, Hey Min; Gallup, Thomas D; Margain, Cori; Gallup, Dave; Rajapakshe, Kimal I; Guerrero, Paola A; Wang, Jing; Corcoran, Ryan B; Maitra, Anirban; Yun, Kyuson; Kopetz, Scott
